vs
Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and NextPlat Corp (NXPL). Click either name above to swap in a different company.
ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $12.8M, roughly 1.8× NextPlat Corp). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -21.1%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -14.4%).
ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.
ADCT vs NXPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $12.8M |
| Net Profit | — | $-5.1M |
| Gross Margin | — | 14.3% |
| Operating Margin | -77.7% | -28.9% |
| Net Margin | — | -40.2% |
| Revenue YoY | 36.4% | -21.1% |
| Net Profit YoY | — | -70.6% |
| EPS (diluted) | $0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.1M | $12.8M | ||
| Q3 25 | $15.8M | $13.8M | ||
| Q2 25 | $18.1M | $13.2M | ||
| Q1 25 | $17.4M | $14.5M | ||
| Q4 24 | $16.9M | $16.2M | ||
| Q3 24 | $18.0M | $15.4M | ||
| Q2 24 | $17.0M | $17.0M | ||
| Q1 24 | $17.8M | $17.5M |
| Q4 25 | — | $-5.1M | ||
| Q3 25 | $-41.0M | $-2.2M | ||
| Q2 25 | $-56.6M | $-1.8M | ||
| Q1 25 | $-38.6M | $-1.3M | ||
| Q4 24 | — | $-3.0M | ||
| Q3 24 | $-44.0M | $-4.2M | ||
| Q2 24 | $-36.5M | $-5.3M | ||
| Q1 24 | $-46.6M | $-1.5M |
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 19.9% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 27.8% |
| Q4 25 | -77.7% | -28.9% | ||
| Q3 25 | -196.6% | -14.5% | ||
| Q2 25 | -244.1% | -13.8% | ||
| Q1 25 | -163.5% | -10.2% | ||
| Q4 24 | -191.8% | -14.1% | ||
| Q3 24 | -197.4% | -52.1% | ||
| Q2 24 | -170.5% | -64.1% | ||
| Q1 24 | -188.3% | -10.5% |
| Q4 25 | — | -40.2% | ||
| Q3 25 | -260.1% | -15.9% | ||
| Q2 25 | -313.2% | -13.5% | ||
| Q1 25 | -221.8% | -9.2% | ||
| Q4 24 | — | -18.6% | ||
| Q3 24 | -244.1% | -27.4% | ||
| Q2 24 | -214.6% | -31.3% | ||
| Q1 24 | -261.1% | -8.5% |
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.30 | — | ||
| Q2 25 | $-0.50 | — | ||
| Q1 25 | $-0.36 | $-0.05 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.42 | $-0.22 | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $-0.56 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.3M | $13.7M |
| Total DebtLower is stronger | — | $1.3M |
| Stockholders' EquityBook value | $-185.8M | $17.3M |
| Total Assets | $323.1M | $27.5M |
| Debt / EquityLower = less leverage | — | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.3M | $13.7M | ||
| Q3 25 | $234.7M | $13.9M | ||
| Q2 25 | $264.6M | $16.6M | ||
| Q1 25 | $194.7M | $17.7M | ||
| Q4 24 | $250.9M | $20.0M | ||
| Q3 24 | $274.3M | $20.4M | ||
| Q2 24 | $300.1M | $24.9M | ||
| Q1 24 | $234.3M | $23.5M |
| Q4 25 | — | $1.3M | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | $-185.8M | $17.3M | ||
| Q3 25 | $-238.2M | $21.4M | ||
| Q2 25 | $-199.2M | $23.5M | ||
| Q1 25 | $-238.2M | $25.3M | ||
| Q4 24 | $-202.6M | $27.3M | ||
| Q3 24 | $-171.9M | $22.5M | ||
| Q2 24 | $-131.7M | $26.5M | ||
| Q1 24 | $-194.4M | $31.2M |
| Q4 25 | $323.1M | $27.5M | ||
| Q3 25 | $289.8M | $30.0M | ||
| Q2 25 | $321.6M | $31.0M | ||
| Q1 25 | $272.5M | $35.2M | ||
| Q4 24 | $322.0M | $37.1M | ||
| Q3 24 | $349.1M | $41.1M | ||
| Q2 24 | $371.8M | $51.5M | ||
| Q1 24 | $308.0M | $65.1M |
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.05× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.1M | $-302.0K |
| Free Cash FlowOCF − Capex | — | $-339.0K |
| FCF MarginFCF / Revenue | — | -2.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.1M | $-302.0K | ||
| Q3 25 | $-29.6M | $-2.7M | ||
| Q2 25 | $-24.1M | $-1.0M | ||
| Q1 25 | $-56.3M | $-2.1M | ||
| Q4 24 | $-21.9M | $-476.0K | ||
| Q3 24 | $-25.0M | $-4.6M | ||
| Q2 24 | $-32.8M | $2.3M | ||
| Q1 24 | $-44.1M | $-2.7M |
| Q4 25 | — | $-339.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | $-56.6M | $-2.1M | ||
| Q4 24 | $-21.9M | $-508.0K | ||
| Q3 24 | $-25.3M | $-4.7M | ||
| Q2 24 | $-32.9M | $2.2M | ||
| Q1 24 | $-44.6M | $-2.7M |
| Q4 25 | — | -2.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -8.0% | ||
| Q1 25 | -325.2% | -14.3% | ||
| Q4 24 | -129.8% | -3.1% | ||
| Q3 24 | -140.2% | -30.6% | ||
| Q2 24 | -193.0% | 13.2% | ||
| Q1 24 | -250.0% | -15.7% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 1.5% | 0.2% | ||
| Q4 24 | 0.5% | 0.2% | ||
| Q3 24 | 1.2% | 0.6% | ||
| Q2 24 | 0.2% | 0.4% | ||
| Q1 24 | 3.0% | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADCT
Segment breakdown not available.
NXPL
| Healthcare Operations | $9.0M | 70% |
| Ecommerce Revenue | $3.8M | 30% |
